Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC grants approval for Merck-Eisai’s combo therapy for endometrial cancer

Pharmaceutical-TechnologyDecember 01, 2021

Tag: Lenvima , tyrosine kinase , Endometrial Cancer

PharmaSources Customer Service